Multidisciplinary Treatment of Malignant Pleural Mesothelioma-Reference-Cited by-同舟云学术

Multidisciplinary Treatment of Malignant Pleural Mesothelioma

Published:2007-07-01 Issue:7 Volume:12 Page:850-863
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Ceresoli Giovanni Luca¹,Gridelli Cesare²,Santoro Armando¹

Affiliation:

1. a Department of Medical Oncology and Hematology, Istituto Clinico Humanitas IRCCS, Rozzano (Milan), Italy

2. b Division of Medical Oncology, “S.G. Moscati” Hospital, Avellino, Italy

Abstract

Learning Objectives After completing this course, the reader will be able to: Select appropriate treatment strategies for patients with MPM.Discuss the clinical development of new agents and therapeutic strategies, and how they could be integrated into the current armamentarium.Summarize the current understandings and pitfalls in staging MPM patients. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-7-850

Reference134 articles.

1. Malignant mesothelioma;Robinson;Lancet,2005

2. Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience;Curran;J Clin Oncol,1998

3. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B;Herndon;Chest,1998

4. Malignant pleural mesothelioma: A disease unaffected by current therapeutic maneuvers;Alberts;J Clin Oncol,1988

5. Malignant mesothelioma of the pleura: A study of 52 treated and 64 untreated patients;Law;Thorax,1984

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma;The Annals of Thoracic Surgery;2019-09

2. Management and Survival of Pleural Mesothelioma: A Record Linkage Study;Respiration;2018

3. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma;European Journal of Radiology;2017-01

4. Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft mouse model;International Journal of Oncology;2016-02-01

5. Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study);BMC Cancer;2015-11-06